Omidria (phenylephrine;ketorolac)
- Region
- 🇪🇺 EU
- Active substance
- phenylephrine;ketorolac
- Company
- Rayner Surgical (Ireland) Limited
- Status
- Authorised
- Therapeutic area
- Lens Implantation, Intraocular; Pain, Postoperative
- CHMP opinion
- Thu 21 May 2015
- EU approval
- Tue 28 Jul 2015
- Application
- EMEA/H/C/003702
- ATC
- S01
- Official record
- www.ema.europa.eu
Indication
Omidria is indicated in adults for maintenance of intraoperative mydriasis, prevention of intraoperative miosis and reduction of acute postoperative ocular pain in intraocular lens replacement surgery.
Regulatory milestones
No milestones recorded in the last year.
Follow Omidria
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.